At Stilla Technologies, we’re pushing boundaries of digital PCR, transforming complex genomic data into clear, actionable insights that drive breakthroughs in cancer research, liquid biopsy, cell and gene therapies, infectious disease detection, and more.
Our next-generation Nio® system combined with our unique detection chemistry deliver actionable insights—so researchers and clinicians can do more, detect more, and discover more with every experiment.
With headquarters in San Diego and Paris, and a strong global presence across China and EMEA, Stilla is setting a new standard in precision genomics.
Join us and push the boundaries of molecular biology like never before. To know more
